Acute bone marrow suppression and gastrointestinal toxicity following acute oral methotrexate overdose

• Published in: Clinical toxicology (Philadelphia, Pa.) Vol. 56; no. 12; pp. 1204 - 1206
• Main Authors: Isoardi, Katherine Z., Harris, Keith, Carmichael, Kate E., Dimeski, Goce, Chan, Betty S. H., Page, Colin B.
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 02.12.2018
• Subjects: folinic acid; Methotrexate; toxicity; toxicity; Methotrexate; folinic acid
• ISSN: 1556-3650; 1556-9519
• DOI: 10.1080/15563650.2018.1484128

Objective: Acute methotrexate overdose rarely causes systemic toxicity due to saturable absorption and rapid renal elimination. We present a case of methotrexate toxicity following acute overdose. Case Report: A 56-year-old female presented soon after an overdose of 1250 mg of methotrexate, zopiclone and tramadol. The methotrexate was initially under-reported (500 mg) and folinic acid was not provided. Despite normal renal function, the patient developed toxicity. She represented 5 days following the overdose with mucositis, bone marrow suppression and prolonged febrile neutropenia. Treatment included folinic acid, broad-spectrum antibiotics, filgrastim, red cell and platelet transfusion. Her bone marrow began to recover 12 days following the overdose. She was discharged home on Day 17. Discussion: Severe toxicity following an acute ingestion of a large amount of methotrexate is rarely reported. The development of toxicity was unexpected in this case given methotrexate's pharmacokinetics and the patient's normal renal function. The serum methotrexate concentrations were below the treatment threshold of the folinic acid rescue therapy nomogram suggesting that the nomogram should not be relied on in acute ingestions. Large acute oral methotrexate poisoning can result in systemic toxicity and folinic acid therapy should be provided in ingestions >1000 mg.